According to a broad European study involving multiple medical institutes, patients with diabetes do not benefit from implantable cardioverter defibrillator (ICD) pacemakers. Current treatment ...

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter–defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ...

BOSTON – Boston Scientific Corp. on Monday said it is recalling some defibrillator and pacemaker models that could fail because of an electrical flaw. The recall is the latest in a string of product ...

Cardiac pacemaker implantations (DRG 116) made the headlines in the first-ever Medicare Quarterly Provider Compliance Newsletter (issued by the Centers for Medicare & Medicaid Services [CMS] just this ...

Dear Dr. Roach: I’m an 88-year-old female who has been diagnosed with ventricular fibrillation. My cardiac electrophysiology doctor, who implanted a conventional pacemaker four years ago, has noticed ...